• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用闪烁扫描法评估来自压力定量吸入器和新型泵喷雾装置的夫沙芬净在口咽和鼻腔的沉积情况。

Scintigraphic assessment of the oropharyngeal and nasal depositions of fusafungine from a pressurized inhaler and from a novel pump spray device.

作者信息

Newman S P, Steed K P, Hooper G, Brickwell J

机构信息

Pharmaceutical Profiles Ltd, Highfields Science Park, Nottingham, UK.

出版信息

J Pharm Pharmacol. 1995 Oct;47(10):818-21. doi: 10.1111/j.2042-7158.1995.tb05747.x.

DOI:10.1111/j.2042-7158.1995.tb05747.x
PMID:8583349
Abstract

The distributions of fusafungine (Locabiotal, Servier) radiolabelled with 99mTc, and delivered either orally or intranasally, have been assessed in healthy volunteers from a pressurized metered-dose aerosol inhaler (125 micrograms per dose) and from a novel mechanical pump spray device (500 micrograms per dose). More than 90% of the dose was initially deposited in the oropharynx for oral dosing (n = 8), and more than 90% in the nose for nasal dosing (n = 9), with no significant penetration of aerosol into the lungs. Although not statistically significant, the mean area of deposition, measured in terms of gamma camera picture elements (pixels), was greater with the pump spray for both oral and nasal dosing. The area of deposition with the nasal pump spray extended into the turbinates in six of nine subjects, compared with only three of nine subjects for the pressurized aerosol. The data suggest that the distribution patterns of pump sprays and pressurized aerosols of fusafungine in the oropharynx and in the nasal passages are similar, and that the former can be substituted for the latter with little change in drug delivery.

摘要

已对健康志愿者使用99mTc标记的夫沙芬净(Locabiotal,施维雅公司)通过定量压力气雾剂吸入器(每剂125微克)和新型机械泵喷雾装置(每剂500微克)经口服或鼻内给药后的分布情况进行了评估。口服给药(n = 8)时,超过90%的剂量最初沉积在口咽部,鼻内给药(n = 9)时,超过90%的剂量沉积在鼻腔,气雾剂无明显进入肺部的情况。尽管无统计学意义,但就γ相机图像元素(像素)而言,口服和鼻内给药时泵喷雾的平均沉积面积均大于定量气雾剂。鼻用泵喷雾的沉积面积在9名受试者中有6名延伸至鼻甲,而定量气雾剂在9名受试者中只有3名如此。数据表明,夫沙芬净的泵喷雾和定量气雾剂在口咽部和鼻腔的分布模式相似,且前者可替代后者,药物递送变化不大。

相似文献

1
Scintigraphic assessment of the oropharyngeal and nasal depositions of fusafungine from a pressurized inhaler and from a novel pump spray device.用闪烁扫描法评估来自压力定量吸入器和新型泵喷雾装置的夫沙芬净在口咽和鼻腔的沉积情况。
J Pharm Pharmacol. 1995 Oct;47(10):818-21. doi: 10.1111/j.2042-7158.1995.tb05747.x.
2
Nasal distribution of radioactive drug administered using two dosage forms.使用两种剂型给药的放射性药物的鼻腔分布。
Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:426-32.
3
Deposition pattern of nasal sprays in man.鼻腔喷雾剂在人体中的沉积模式。
Rhinology. 1988 Jun;26(2):111-20.
4
Breath actuated device improves delivery to target sites beyond the nasal valve.呼吸驱动装置可改善药物递送至鼻瓣以外的靶部位。
Laryngoscope. 2006 Mar;116(3):466-72. doi: 10.1097/01.MLG.0000199741.08517.99.
5
Pulsating aerosols for drug delivery to the sinuses in healthy volunteers.脉冲式气溶胶在健康志愿者鼻窦内的药物输送。
Otolaryngol Head Neck Surg. 2010 Mar;142(3):382-8. doi: 10.1016/j.otohns.2009.12.028.
6
Nasal deposition and clearance in man: comparison of a bidirectional powder device and a traditional liquid spray pump.鼻腔沉积和清除在人类中的比较:双向粉末装置与传统液体喷雾泵的比较。
J Aerosol Med Pulm Drug Deliv. 2012 Oct;25(5):280-9. doi: 10.1089/jamp.2011.0924. Epub 2012 Jan 17.
7
Comparison of in vitro and in vivo efficiencies of a novel unit-dose liquid aerosol generator and a pressurized metered dose inhaler.新型单位剂量液体气雾剂发生器与压力定量吸入器的体外和体内效率比较
Int J Pharm. 2000 Mar 30;198(1):63-70. doi: 10.1016/s0378-5173(99)00452-4.
8
Nasal distribution of budesonide inhaled via a powder inhaler.通过粉雾剂吸入的布地奈德在鼻腔的分布。
Rhinology. 1993 Mar;31(1):7-10.
9
Nasally inhaled pulsating aerosols: lung, sinus and nose deposition.经鼻吸入式脉动气雾剂:肺部、鼻窦和鼻腔沉积。
Rhinology. 2011 Aug;49(3):286-91. doi: 10.4193/Rhino10.268.
10
Drug delivery to the nasal cavity: in vitro and in vivo assessment.鼻腔给药:体外和体内评估
Crit Rev Ther Drug Carrier Syst. 2004;21(1):21-66.

引用本文的文献

1
Measurement of drug in small particles from aqueous nasal sprays by Andersen Cascade Impactor.用安德森级联撞击器测量水性鼻喷雾剂中小颗粒中的药物。
Pharm Res. 2012 Nov;29(11):3122-30. doi: 10.1007/s11095-012-0804-7. Epub 2012 Jul 3.